 BAUDETTE, Minn.--BUSINESS WIRE--ANI Pharmaceuticals, Inc. ANI or the Company NASDAQ: ANIP today announced business highlights and financial results for the three and six months ended June 30, 2021. Second Quarter and Recent Business Highlights: The Company refiled its supplemental new drug application sNDA for Cortrophin Gel with the U.S. Food and Drug Administration FDA or the Agency on June 29, 2021; goal date is October 29, 2021; Acquisition of Novitium Pharma LLC Novi 